(Q47824495)

English

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

scientific article published on 10 September 2017

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit